Back

The association between transcriptional regulation of macrophage differentiation and activation and genetic susceptibility to inflammatory bowel disease

Hume, D. A.; O'Brien, C.; Summers, K. M.; Martin, N. M.; Carter-Cusack, D.; Barua, R.; Dixit, O. V.; Pavli, P.

2022-12-15 genetics
10.1101/2022.12.14.520373 bioRxiv
Show abstract

The abundant macrophage population of the intestinal lamina propria turns over rapidly and is replaced by blood monocytes. The differentiation and survival of resident intestinal macrophages depends upon signals from the macrophage colony-stimulating factor receptor (CSF1R). The response of human monocyte-derived macrophages (MDM) grown in macrophage colony-stimulating factor (CSF1) to bacterial lipopolysaccharide (LPS) has been proposed as a model for the differentiation and adaptation of monocytes entering the intestinal lamina propria. We hypothesized that dysregulation of this response leads to susceptibility to chronic inflammatory bowel disease (IBD). To address this hypothesis we analyzed transcriptomic variation in MDM from affected and unaffected sib pairs/trios from 22 IBD families and 6 healthy controls. There was no overall or inter-sib distinction between affected and unaffected individuals in basal gene expression or the stereotypical time course of the response to LPS. However, the basal or LPS-inducible expression of individual genes including inflammatory cytokines and many associated with IBD susceptibility in genome-wide association studies (GWAS) varied by as much as 100-fold between subjects. Extreme independent variation in the expression of pairs of HLA-associated transcripts (HLA-B/C, HLA-A/F and HLA-DRB1/DRB5) was associated with HLA genotype providing a novel explanation for the HLA association with disease susceptibility. The relationship between single nucleotide variant (SNV) genotype and gene expression at other loci was weaker and inconsistent suggesting that much of the variation arises from the integration of multiple trans-acting effects. For example, expression of IL1B at 2 hrs of LPS treatment was significantly associated with local SNV genotype and with peak expression of IL23A at 7 hrs. By contrast, there was no evidence of association between peak IL6 mRNA at 7hrs, IL6-associated SNV genotype or IL1B at 2 hrs. Our results support the view that gene-specific dysregulation in macrophage adaptation to the intestinal milieu provides a plausible explanation for genetic susceptibility to IBD. The analysis also suggests that the molecular basis of susceptibility is unique to each individual which may contribute to variation in the precise environmental trigger, the consequent pathology and response to treatment. Author summaryCells of the innate immune system called macrophages are abundant in the wall of the gut, providing a first line of defense against potential pathogens. These cells must also avoid an inappropriate or excessive response to the abundant microbial population (the microbiome) of the intestine. We have previously proposed that genetic differences between individuals in macrophage adaptation to the unique environment of the intestine underlie genetic susceptibility to inflammatory bowel disease (IBD). In this study we developed a model of the adaptation of macrophages and used that model to identify surprisingly extreme variation in the response amongst a cohort of affected and unaffected siblings in families with IBD. The response did not distinguish affected individuals from their unaffected siblings. Our results support the view that each individual within IBD-susceptible families carries a unique set of genetic variants of large effect that together predispose to uncontrolled gut inflammation in the face of an environmental trigger.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 12%
15.2%
2
PLOS Genetics
862 papers in training set
Top 0.6%
12.8%
3
Human Molecular Genetics
141 papers in training set
Top 0.1%
9.8%
4
Genes & Immunity
11 papers in training set
Top 0.1%
5.6%
5
Genome Medicine
183 papers in training set
Top 0.6%
5.5%
6
International Journal of Molecular Sciences
494 papers in training set
Top 2%
4.3%
50% of probability mass above
7
Frontiers in Genetics
230 papers in training set
Top 0.7%
4.3%
8
BMC Genomics
406 papers in training set
Top 2%
3.5%
9
Frontiers in Immunology
638 papers in training set
Top 4%
3.2%
10
Scientific Reports
3612 papers in training set
Top 40%
2.7%
11
BMC Medical Genomics
50 papers in training set
Top 0.3%
2.4%
12
Genes
144 papers in training set
Top 2%
1.9%
13
The FEBS Journal
93 papers in training set
Top 0.6%
1.9%
14
PLOS Pathogens
820 papers in training set
Top 6%
1.7%
15
eLife
5828 papers in training set
Top 53%
1.4%
16
Inflammatory Bowel Diseases
16 papers in training set
Top 0.2%
1.4%
17
BMC Genomic Data
13 papers in training set
Top 0.1%
1.1%
18
Wellcome Open Research
67 papers in training set
Top 1%
1.1%
19
G3 Genes|Genomes|Genetics
351 papers in training set
Top 3%
1.1%
20
Journal of Crohn's and Colitis
11 papers in training set
Top 0.1%
1.0%
21
BMC Biology
265 papers in training set
Top 5%
0.8%
22
iScience
1154 papers in training set
Top 34%
0.8%
23
PLOS Biology
486 papers in training set
Top 11%
0.8%
24
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 44%
0.6%
25
Clinical Immunology
21 papers in training set
Top 0.5%
0.6%